Mar 23, 2023, 4:00 PM EDT
Sanofi takes another big hit as it halts work on breast cancer medication, amcenestrant
French healthcare company Sanofi has decided to halt work on its once praised breast cancer medication amcenestrant after a second failed clinical trial.
Possible new Sanofi-GSK coronavirus vaccine showing promise in trials, companies say
A possible new coronavirus vaccine candidate produced by Sanofi and GSK (GlaxoSmithKline) that uses the human body’s own antigens to neutralize antibody responses for people who have already recovered from the illness, has completed Phase 2 trials, the companies said Monday.
Next generation coronavirus vaccine in pill, spray forms could have these benefits, Dr. Nesheiwat explains
Fox News medical contributor Dr. Janette Nesheiwat broke down to "Kudlow" that a wider range of coronavirus vaccine options would be beneficial for pandemic recovery as well as personal health.